Public, NASDAQ:BCRX
NASDAQ Global Market
Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment ...
Date: Tue, 07 Feb 2012 01:03:04 GMT
Tags:
Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment ...
BioMedReports (subscription) - Feb 7, 2012
BioMedReports (subscription) - Feb 7, 2012
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on February 6, 2012.
BIOCRYST PHARMACEUTICALS, INC.: BioCryst to Announce Fourth Quarter and Fu..
Date: Mon, 06 Feb 2012 11:53:46 GMT
Tags:
BIOCRYST PHARMACEUTICALS, INC.: BioCryst to Announce Fourth Quarter and Fu..
4-traders (press release) - Feb 6, 2012
4-traders (press release) - Feb 6, 2012
BioCryst Pharmaceuticals, Inc. : BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012 BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that its fourth quarter and full year 2011 financial results ...
BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on ... - MarketWatch (press release)14 Rallying Biotech Stocks Being Snapped Up By Insiders
Date: Thu, 02 Feb 2012 06:17:14 GMT
Tags:
14 Rallying Biotech Stocks Being Snapped Up By Insiders
Seeking Alpha - Feb 2, 2012
Seeking Alpha - Feb 2, 2012
Want to know the inside scoop? One of the best sources for what company insiders actually think about their companies is trends in insider buying.
Nancy Hutson Appointed to BioCryst's Board of Directors
Date: Thu, 19 Jan 2012 11:47:24 GMT
Tags:
Nancy Hutson Appointed to BioCryst's Board of Directors
MarketWatch (press release) - Jan 19, 2012
MarketWatch (press release) - Jan 19, 2012
RESEARCH TRIANGLE PARK, NC, Jan 19, 2012 (BUSINESS WIRE) -- BioCryst Pharmaceuticals, Inc., /quotes/zigman/54089/quotes/nls/bcrx BCRX -1.06% today announced that Nancy J. Hutson, Ph.
Top Gainers in After-hours Today, Jan-12
Date: Thu, 12 Jan 2012 22:05:43 GMT
Tags:
Top Gainers in After-hours Today, Jan-12
Beacon Equity Research - Jan 12, 2012
Beacon Equity Research - Jan 12, 2012
Response Genetics Inc (NASDAQ:RGDX) is currently trading at $1.58 up 12.1% in after-hours on 9500 shares traded. RGDX is trading -4.54% below its 50 day moving average and -32.13% below its 200 day moving average.
3 Biotech Companies Down But Not Out
Date: Wed, 08 Feb 2012 09:49:17 GMT
Tags:
BioCryst to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012
Date: Mon, 06 Feb 2012 11:45:00 GMT
Tags:
[Business Wire] - BioCryst Pharmaceuticals, Inc. today announced that its fourth quarter and full year 2011 financial results will be released on Thursday, February 16, 2012. BioCryst will host a conference call and webcast at 11:00 a.m.
14 Rallying Biotech Stocks Being Snapped Up By Insiders
Date: Thu, 02 Feb 2012 06:05:52 GMT
Tags:
Gilead Sciences Inc. Fourth Quarter Earnings Sneak Peek
Date: Mon, 30 Jan 2012 17:09:35 GMT
Tags:
BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure,
Date: Fri, 20 Jan 2012 16:55:44 GMT
Tags: